News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

US Senate Panel Backs 12-Year Biotech Drug Shelter; Major Victory for Drug Makers Such as Amgen (AMGN), Roche Holding AG (RHHBF.PK)


7/14/2009 7:47:11 AM

Reuters -- Biotechnology medicines would be protected from cheaper rivals for 12 years under a plan that cleared a U.S. Senate committee on Monday.

Read at Reuters
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES